hipsc-derived imscs (NextGen Sciences)
90
Structured Review
NextGen Sciences
hipsc-derived imscs
Hipsc Derived Imscs, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hipsc-derived+imscs/hipsc+derived+imscs/pm33743834-370-2-6
Average 90 stars, based on 1 article reviews
Hipsc Derived Imscs, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hipsc-derived+imscs/hipsc+derived+imscs/pm33743834-370-2-6
Average 90 stars, based on 1 article reviews
hipsc-derived imscs - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation. Article Snippet: Sabapathy V, Article Title: 3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium. Article Snippet: Common events in the clinic, such as uterine curettage or inflammation, may lead to irreversible endometrial damage, often resulting in infertility in women of childbearing age.. Currently, tissue engineering has the potential to achieve tissue manipulation, regeneration, and growth, but personalization and precision remain challenges.. The application of “3D cell printing” is more in line with the clinical requirements of tissue repair. Article Title: Zebrafish embryo extract counteracts human stem cell senescence Article Snippet: 1Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy, 2Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy, 3Medical Technology Laboratory, Rizzoli Orthopaedic Institute, Via di Barbiano, 1/10, 40136 Bologna, Italy, 4Scientific Institute of Research and Care Multimedica, Via Milanese, 300, 20099 Sesto San Giovanni (Milano), Italy, 5National Laboratory of Molecular Biology and Stem Cell Bioengineering of the National Institute of Biostructures and Biosystems (NIBB), Eldor Lab, at the Innovation Accelerator, CNR, Via Piero Gobetti, 101, 40129 Bologna, Italy, 6Center for developmental biology and reprogramming, CEDEBIOR, Department of Biomedical Sciences, University of Sassari and National Institute of Biostructures and Biosystems, Viale San Pietro, 43/B, 07100 Sassari, Italy, 7Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, S.S 554 bivio per Sestu Km 4,500, 09042 Monserrato (Cagliari), Italy, 8Department of Biotechnology, University of Natural Resources and Life Sciences, Muthgasse, 18, A-1190 Vienna, Austria, 9Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, Donaueschingenstrasse, 13, A-1200 Vienna, Austria Article Title: Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns. Article Snippet: 150 words) While wound therapy remains a clinical challenge in current medical practice, much effort has focused on developing biological therapeutic approaches.. This paper presents a comprehensive review of delivery systems for current biologicals for the treatment of chronic wounds and severe burns.. The biologicals discussed here include proteins such as growth factors and gene modifying molecules, which may be delivered to wounds free, encapsulated, or released from living systems (cells, skin grafts or skin equivalents) or biomaterials. Article Title: Generation of integration-free induced pluripotent stem cells from blood-derived cells isolated from patient with severe haemophilia A. Article Snippet: Haemophilia.. 2019;1–5. wileyonlinelibrary.com/journal/hae | 1© 2019 John Wiley & Sons Ltd Received: 24 September 2018 | Revised: 11 January 2019 | Accepted: 30 January 2019 DOI: 10.1111/hae.13716 L E T T E R T O T H E E D I T O R Generation of integration‐free induced pluripotent stem cells from blood‐derived cells isolated from patient with severe haemophilia A Haemophilia A (HA) is a severe, congenital bleeding disorder caused by the deficiency of clotting factor VIII (FVIII).1 Human induced plu‐ ripotent stem cells (iPSCs) are useful for in vitro HA modelling.. These patient‐specific pluripotent cells can be used in pharmacological tests of new drugs and provide an applicable cell source for cell ther‐ apy after genetic correction in vitro.2 Here, we report a modelling for HA using iPSC integration‐free technology from peripheral blood cells of a severe HA patient. Article Title: The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts. Article Snippet: [162] V. Sabapathy, S. Kumar, |